Abstract
Background: One of the main subsidizing factors to the rising healthcare costs are related to the design and development of visionary pharmaceutical products. As a consequence, healthcare authorities have identified herbal preventive and therapeutic options as possible alternative strategies. In the developing world, there is an urgent need for the pharmaceutical industry field to invest more time and resources in the research and development of complementary and alternative medicines. Purpose: The main aim of this study was to contribute to the development of an innovative phyto-based formulation for topical application and determine its thermal stability chronically. Material and Methods: A cream of water-in-oil type emulsion was prepared and implemented or not (placebo aka base) with Muscat hamburg black grape extract (active formulation). M. hamburg-based cream was first mixed with the emulsifier (i.e. Abile EM90® aka Dimethicone) and compared with a placebo. Successful formulations were selected based on their ability to remain significantly (p 0.05) when all respective samples were assessed. In spite of a progressive time-dependent and temperature-independent decline of the mean pH in both placebo and active formulation, the mean pH of both emulsions fit the acceptable range of dermal pH (i.e. 4.5-6.5) for 21 days. Conclusions: The in-vitro evaluation of our newly developed dimethicone based cream containing Muscat hamburg extract showed satisfactory and promising results for its possible use as a topical semi-solid dosage form for various skin ailments.
Highlights
Emulsion is a dispersed system stabilized by an emulsifying agent, which is constituted of small globules of liquid known as dispersed phase, distributed in another immiscible solvent called dispersion medium [1]
In our experimental conditions and from our comparative analyses, we noticed (i) unchanged organoleptic properties in terms of appearance, color and odor; (ii) unchanged properties after centrifugation and phase separation, and in terms of electrical conductivity, liquefaction, or viscosity. We showed that both placebo and active formulation had insignificant mean pH (5.12 ± 0.43 versus 5.04 ± 0.39, p>0.05) when all respective samples were assessed
In spite of a progressive time-dependent and temperature-independent decline of the mean pH in both placebo and active formulation, the mean pH of both emulsions fit the acceptable range of dermal pH (i.e. 4.5-6.5) for 21 days
Summary
Emulsion is a dispersed system stabilized by an emulsifying agent, which is constituted of small globules of liquid known as dispersed phase, distributed in another immiscible solvent called dispersion medium [1]. The emulsifying agent possesses hydrophilic and hydrophobic groups [2], adsorbed at the interphase of water and oil, and reduces the interfacial tension. This helps in the distribution of dispersed phase globules [3]. The oily phase used is comprised of paraffin oil It is transparent, tasteless and colorless liquid, odorless at cold temperatures but gives faint petroleum like odor when heated [5]. There is an urgent need for the pharmaceutical industry field to invest more time and resources in the research and development of complementary and alternative medicines.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Pharmaceutical Care & Health Systems
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
